» Articles » PMID: 28097232

Vps34 Regulates Myofibril Proteostasis to Prevent Hypertrophic Cardiomyopathy

Abstract

Hypertrophic cardiomyopathy (HCM) is a common heart disease with a prevalence of 1 in 500 in the general population. Several mutations in genes encoding cardiac proteins have been found in HCM patients, but these changes do not predict occurrence or prognosis and the molecular mechanisms underlying HCM remain largely elusive. Here we show that cardiac expression of vacuolar protein sorting 34 (Vps34) is reduced in a subset of HCM patients. In a mouse model, muscle-specific loss of Vps34 led to HCM-like manifestations and sudden death. Vps34-deficient hearts exhibited abnormal histopathologies, including myofibrillar disarray and aggregates containing αB-crystallin (CryAB). These features result from a block in the ESCRT-mediated proteolysis that normally degrades K63-polyubiquitinated CryAB. CryAB deposition was also found in myocardial specimens from a subset of HCM patients whose hearts showed decreased Vps34. Our results identify disruption of the previously unknown Vps34-CryAB axis as a potentially novel etiology of HCM.

Citing Articles

Preserving mitochondria to treat hypertrophic cardiomyopathy: From rare mitochondrial DNA mutation to heart failure therapy?.

Diwan A J Clin Invest. 2023; 133(14).

PMID: 37463442 PMC: 10348762. DOI: 10.1172/JCI171965.


Regulated cell death pathways in cardiomyopathy.

Sheng S, Li J, Hu X, Wang Y Acta Pharmacol Sin. 2023; 44(8):1521-1535.

PMID: 36914852 PMC: 10374591. DOI: 10.1038/s41401-023-01068-9.


Autophagy in striated muscle diseases.

Li H, Zhang L, Zhang L, Han R Front Cardiovasc Med. 2022; 9:1000067.

PMID: 36312227 PMC: 9606591. DOI: 10.3389/fcvm.2022.1000067.


Class III PI3K Biology.

Caux M, Chicanne G, Severin S Curr Top Microbiol Immunol. 2022; 436:69-93.

PMID: 36243840 DOI: 10.1007/978-3-031-06566-8_3.


ATG14 and RB1CC1 play essential roles in maintaining muscle homeostasis.

Li D, Vogel P, Li-Harms X, Wang B, Kundu M Autophagy. 2021; 17(9):2576-2585.

PMID: 33794726 PMC: 8496527. DOI: 10.1080/15548627.2021.1911549.


References
1.
Duncan L, Piper S, Dodd R, Saville M, Sanderson C, Luzio J . Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 2006; 25(8):1635-45. PMC: 1440841. DOI: 10.1038/sj.emboj.7601056. View

2.
Bruning J, Michael M, Winnay J, Hayashi T, Horsch D, Accili D . A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998; 2(5):559-69. DOI: 10.1016/s1097-2765(00)80155-0. View

3.
Seiler C, Jenni R, Vassalli G, Turina M, Hess O . Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy. Br Heart J. 1995; 74(5):508-16. PMC: 484070. DOI: 10.1136/hrt.74.5.508. View

4.
Dalakas M, Park K, Semino-Mora C, Lee H, Sivakumar K, Goldfarb L . Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med. 2000; 342(11):770-80. DOI: 10.1056/NEJM200003163421104. View

5.
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P . Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2007; 29(2):270-6. DOI: 10.1093/eurheartj/ehm342. View